Bloomage Biotechnology Corp Ltd Total Assets

Latest as of March 2026: CN¥8.75 Billion CNY ≈ $1.28 Billion USD

Bloomage Biotechnology Corp Ltd total assets. Based on the latest financial reports, Bloomage Biotechnology Corp Ltd (688363) holds total assets worth CN¥8.75 Billion CNY (≈ $1.28 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Bloomage Biotechnology Corp Ltd market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of Bloomage Biotechnology Corp Ltd (2012–2025)

Total assets of Bloomage Biotechnology Corp Ltd from 2012 to 2025. This chart illustrates how Bloomage Biotechnology Corp Ltd's total assets have evolved over time, based on quarterly financial data. See today's stock price for Bloomage Biotechnology Corp Ltd for real-time trading data and today's change.

Bloomage Biotechnology Corp Ltd - Asset Composition Analysis

Bloomage Biotechnology Corp Ltd Total Assets Breakdown (December 2025)

Bloomage Biotechnology Corp Ltd total assets breakdown as of December 2025. Bloomage Biotechnology Corp Ltd's total assets of CN¥8.75 Billion consist of 32.0% current assets and 68.0% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	11.5%
Accounts Receivable	CN¥564.47 Million	6.5%
Inventory	CN¥980.62 Million	11.3%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥517.62 Million	6.0%
Goodwill	CN¥177.62 Million	2.0%

Asset Composition Trend (2012–2025)

This chart illustrates how Bloomage Biotechnology Corp Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore 688363 working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Bloomage Biotechnology Corp Ltd's current assets represent 32.0% of total assets in 2025, a decrease from 54.7% in 2012.
Cash Position: Cash and equivalents constituted 11.5% of total assets in 2025, down from 25.5% in 2012.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 0.0% in 2012.
Asset Diversification: The largest asset category is inventory at 11.3% of total assets.

Bloomage Biotechnology Corp Ltd Competitors by Total Assets

Key competitors of Bloomage Biotechnology Corp Ltd based on total assets are shown below.

Company	Country	Total Assets
NOVOZYMES A/S SPONS.ADR 1 F:NZM	Germany	€16.52 Billion
Swancor Advanced Materials Co Ltd SHG:688585	China	CN¥2.24 Billion
LB Group Co Ltd SHE:002601	China	CN¥63.89 Billion
Suzhou TA&A Ultra Clean Technology Co Ltd SHE:300390	China	CN¥27.92 Billion
Azelis Group NV BR:AZE	Belgium	€5.72 Billion
Himadri Speciality Chemical Limited NSE:HSCL	India	Rs63.06 Billion
Baoding Lucky Innovative Materials Co Ltd SHE:300446	China	CN¥11.13 Billion
Anhui Shenjian New Materials Co Ltd SHE:002361	China	CN¥4.62 Billion

Bloomage Biotechnology Corp Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.36	2.37	4.05
Quick Ratio	1.59	1.27	3.42
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥1.65 Billion	CN¥1.53 Billion	CN¥2.86 Billion

Bloomage Biotechnology Corp Ltd - Advanced Valuation Insights

This section examines the relationship between Bloomage Biotechnology Corp Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.61
Latest Market Cap to Assets Ratio	0.28
Asset Growth Rate (YoY)	0.4%
Total Assets	CN¥8.69 Billion
Market Capitalization	$2.44 Billion USD

Valuation Analysis

Below Book Valuation: The market values Bloomage Biotechnology Corp Ltd's assets below their book value (0.28x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Bloomage Biotechnology Corp Ltd's assets grew by 0.4% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Bloomage Biotechnology Corp Ltd (2012–2025)

The table below shows the annual total assets of Bloomage Biotechnology Corp Ltd from 2012 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥8.69 Billion ≈ $1.27 Billion	+0.41%
2024-12-31	CN¥8.66 Billion ≈ $1.27 Billion	+2.20%
2023-12-31	CN¥8.47 Billion ≈ $1.24 Billion	-2.44%
2022-12-31	CN¥8.68 Billion ≈ $1.27 Billion	+15.70%
2021-12-31	CN¥7.50 Billion ≈ $1.10 Billion	+31.26%
2020-12-31	CN¥5.72 Billion ≈ $836.56 Million	+14.99%
2019-12-31	CN¥4.97 Billion ≈ $727.51 Million	+140.06%
2018-12-31	CN¥2.07 Billion ≈ $303.05 Million	+9.98%
2017-12-31	CN¥1.88 Billion ≈ $275.55 Million	+11.81%
2016-12-31	CN¥1.68 Billion ≈ $246.45 Million	-23.42%
2015-12-31	CN¥2.20 Billion ≈ $321.81 Million	+127.79%
2014-12-31	CN¥965.44 Million ≈ $141.27 Million	+25.66%
2013-12-31	CN¥768.31 Million ≈ $112.43 Million	+62.00%
2012-12-31	CN¥474.26 Million ≈ $69.40 Million	--

About Bloomage Biotechnology Corp Ltd

SHG:688363 China Specialty Chemicals

Market Cap

$2.44 Billion

CN¥16.65 Billion CNY

Market Cap Rank

#5368 Global

#912 in China

Share Price

CN¥34.56

Change (1 day)

-0.58%

52-Week Range

CN¥32.78 - CN¥51.77

All Time High

CN¥303.37